CSIMarket Company Name, Ticker, Customers, else..
 
Tff Pharmaceuticals Inc  (NASDAQ: TFFP)
Other Ticker:  
 
 
Price: $0.0650 $-0.10 -60.049%
Day's High: $0.0902 Week Perf: -77.57 %
Day's Low: $ 0.06 30 Day Perf: -95.99 %
Volume (M): 11,020 52 Wk High: $ 11.00
Volume (M$): $ 716 52 Wk Avg: $3.05
Open: $0.09 52 Wk Low: $0.06



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 4
 Employees 25
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -18
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Tff Pharmaceuticals Inc
Tff Pharmaceuticals Inc is a pharmaceutical company that focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology. TFF technology provides enhanced drug delivery solutions for various therapeutic areas such as lung diseases, ophthalmic disorders, and rare diseases. The company aims to improve patient outcomes by delivering drugs more effectively and efficiently.


   Company Address: 1751 River Run Fort Worth 76107 TX
   Company Phone Number: 438-6168   Stock Exchange / Ticker: NASDAQ TFFP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARDX   -14.8%    
CAPR        7.7% 
HOOK        9.55% 
MRUS   -2.47%    
SBFM        0.3% 
TSVT        5.24% 
• View Complete Report
   



Product Service News

TFF Pharmaceuticals to Cease Operations, Impacting Employees and Stakeholders,

Published Thu, Nov 14 2024 9:15 PM UTC

TFF Pharmaceuticals Announces Wind Down of Operations FORT WORTH, Texas, November 14, 2024 TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) has made a significant announcement regarding the future of the company. In a recent statement, the board of directors disclosed their decision to terminate all employees and wind down operations. This move comes after a special meeting of th...
Clinical Study

Transforming Therapeutics TFF Pharmaceuticals Heralds a New Era in Pulmonary Drug Delivery with Innovative Techn...

Published Thu, Sep 26 2024 11:01 AM UTC

The quest for improved delivery methods for pharmaceutical treatments has led researchers to explore diverse routes, with inhalational therapy gaining momentum due to its potential for localized and efficient drug administration. TFF Pharmaceuticals is at the forefront of this innovative field, as highlighted by two significant developments in their research the exploratio...
Partnership

Pioneering Collaboration TFF Pharmaceuticals, Emory University, and BARDA Join Forces to Combat Influenza and COVID w...

Published Wed, Sep 11 2024 11:00 AM UTC

In an unprecedented cooperative effort aimed at innovating treatments for respiratory illnesses, TFF Pharmaceuticals has formed a strategic partnership with Emory University and the Biomedical Advanced Research and Development Authority (BARDA). This collaboration is centered around the development of a dry powder inhaled formulation of messenger RNA (mRNA) aimed at addressi...
Clinical Study

TFF Pharmaceuticals A Promising Influenza Vaccine Facing Financial Headwinds,

Published Tue, Sep 10 2024 11:00 AM UTC

In a significant development for public health, TFF Pharmaceuticals recently announced promising preclinical data from its bivalent universal influenza vaccine candidates. Manufactured by TFF, these vaccine candidates demonstrated the ability to induce neutralizing antibody titers in ferrets against the H1 and H3 influenza strains following intranasal immunization. However, ...
Clinical Study

Promising Outcomes and Accelerated Enrollment in Phase 2 Trial of Tacrolimus Inhalation Powder for Lung Transpl...

Published Tue, Aug 6 2024 12:01 PM UTC

Abstract This article reports on the ongoing favorable outcomes from TFF Pharmaceuticals Phase 2 trial of Tacrolimus Inhalation Powder (TFF TAC) designed for the prevention of lung transplant rejection, noting accelerated patient enrollment. Lung transplantation is a life-saving procedure for patients with various end-stage pulmonary diseases. However, post-transplant reje...






Tff Pharmaceuticals Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com